Slide 1PCRRT and ECMO A. Dodge-Khatami, MD, PhD Division of Congenital Cardiovascular Surgery University Childrens Hospital, University of Zürich, Switzerland K NDERSPITAL…
Slide 1MANAGEMENT OF COMPLICATIONS OF PIH : AN OVERVIEW Slide 2 DR.VANDANA WALVEKAR Former Dean, Nowrosjee Wadia Maternity Hospital, Former President, Mumbai Obs and Gyn…
Slide 1Drugs Used in Coagulation Disorder Anticoagulant Drugs Fibrolytic Drugs Antithrombotic / Antiplatelet Drugs Slide 2 Hemostasis Hemostasis is the arrest of blood loss…
Slide 1PARTICULATE AIR POLLUTION AND MYOCARDIAL INFARCTION: EXPLAINING THE CONNECTION Howard M. Kipen, MD, MPH NJ Clean Air Council April 13, 2005 Slide 2 Coronary Artery…
Slide 1Chapter 31 Antithrombotic therapy August 8, 2005 Slide 2 Heparin induced thrombocytopenia (HIT) Characterized by formation of antibodies against the heparin-platelet…
Slide 1ASA - Is there a Primary Prevent Indication in Diabetes? Contemporary Therapeutic Issues in Cardiovascular Disease Saturday, May 8 th, 2010 Patrick Robertson, BSP,…
Slide 1The SELECT-ACS Trial Effects of the P-selectin antagonist inclacumab on myocardial damage after PCI for NSTEMI Effects of the P-selectin antagonist inclacumab on myocardial…
1.stroke is the clinical term for acute loss of circulation to an area of the brain, resulting in ischemia and a corresponding loss of neurologic function .Classified as…